NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
2,500
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Neogenomics Inc. market cap is $2.07B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Neogenomics Inc. 52 week high is $20.15 as of November 15, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Neogenomics Inc. 52 week low is $7.07 as of November 15, 2026.
Neogenomics Inc. stock price today is $16.02.
Neogenomics Inc. stock price yesterday was $16.54.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Neogenomics Inc.'s P/E ratio is -63.88.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Neogenomics Inc. P/B ratio is 2.5832.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Neogenomics Inc. 50-day moving average is $17.55.
